PLLA and CaHA-R for Aesthetic Rejuvenation

PHASE4RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

December 1, 2026

Conditions
Aesthetic
Interventions
DEVICE

Sculptra Aesthetic

"Sculptra® Aesthetic is manufactured by Galderma Laboratories. It is a sterile, lyophilized preparation of PLLA that is biocompatible and biodegradable. Each vial contains 367.5 mg of freeze-dried powder, including 150 mg of PLLA. Prior to injection, it will be reconstituted with sterile water for injection (SWFI) and lidocaine hydrochloride (2%).~For this study, commercial products will be used. The study products are for single use only."

DEVICE

Radiesse

"Radiesse® is manufactured by Merz Aesthetics. It is a sterile, non-pyrogenic, semi-solid injectable implant composed of synthetic CaHA suspended in a gel carrier of sterile water, glycerin, and sodium carboxymethylcellulose. Each pre-filled syringe contains 1.5 mL of product. The product includes 0.3% lidocaine for pain reduction during injection.~For this study, commercial products will be used. The study products are for single use only."

Trial Locations (1)

H3Z 1C3

RECRUITING

Erevna Innovations Inc., Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER